| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f02dc2b2dfa70dd2b7093fc3a4753438 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2810-6018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 |
| filingDate |
2009-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30a48e0999f72a92001eade07047ae39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd8c52360437f3b6080b121196a03d76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15231cfa240c0a632ec54389d88cff82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37e7cf51929e887530bf133750b23886 |
| publicationDate |
2011-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110096579-A |
| titleOfInvention |
Oncolytic adenovirus vectors and related methods and uses |
| abstract |
The present invention relates to the field of life sciences and medicine. In particular, the present invention relates to cancer therapy. More specifically, the present invention relates to oncolytic adenovirus vectors and cells and pharmaceutical compositions comprising the vectors. The present invention further relates to the use of the vector in the manufacture of a medicament for the treatment of cancer in a subject and a method of treating cancer in a subject. Moreover, the present invention is not only a method for producing GM-CSF in a cell and increasing a tumor specific immune response of a subject, but also a method for producing GM-CSF in a cell and increasing a tumor specific immune response in a subject. To oncolytic adenovirus vectors for |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021194183-A1 |
| priorityDate |
2008-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |